Anti-Hu CD178 Purified

*Ji J, Chen JJ, Braciale VL, Cloyd MW: Apoptosis induced in HIV-1-exposed, resting CD4+ T cells subsequent to signaling through homing receptors is Fas/Fas ligand-mediated. J Leukoc Biol. 2007 Jan;81 (1) :297-305., URL: http://www.ncbi.nlm.nih.gov/pubmed/17056762 , *Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H: Metalloproteinase-mediated release of human Fas ligand. J Exp Med. 1995 Dec 1;182 (6) :1777-83., URL: http://www.ncbi.nlm.nih.gov/pubmed/7500022 , *Jodo S, Pidiyar VJ, Xiao S, Furusaki A, Sharma R, Koike T, Ju ST: Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated cytotoxicity. J Immunol. 2005 Apr 15;174 (8) :4470-4., URL: http://www.ncbi.nlm.nih.gov/pubmed/15814666, *Ghadimi MP, Sanzenbacher R, Thiede B, Wenzel J, Jing Q, Plomann M, Borkhardt A, Kabelitz D, Janssen O: Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178) . FEBS Lett. 2002 May 22;519 (1-3) :50-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=sanzenbacher+r+thiede+b , *Chopin D, Barei-Moniri R, Maillé P, Le Frè re-Belda MA, Muscatelli-Groux B, Merendino N, Lecerf L, Stoppacciaro A, Velotti F: Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression. Am J Pathol. 2003 Apr;162 (4) :1139-49., URL: http://www.ncbi.nlm.nih.gov/pubmed/12651606